145 related articles for article (PubMed ID: 37733140)
1. Prevalence of Type III Secretion System (T3SS) and Biofilm Development in Genetically Heterogeneous Clinical Isolates of Pseudomonas aeruginosa from Nigeria.
Olaniran OB; Donia A; Adeleke OE; Bokhari H
Curr Microbiol; 2023 Sep; 80(11):349. PubMed ID: 37733140
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Virulence Genes Associated with Type III Secretion System and Biofilm Formation in Pseudomonas aeruginosa Clinical Isolates.
Ali ASBE; Ozler B; Baddal B
Curr Microbiol; 2023 Oct; 80(12):389. PubMed ID: 37880467
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial Resistance and Type III Secretion System Virulotypes of Pseudomonas aeruginosa Isolates from Dogs and Cats in Primary Veterinary Hospitals in Japan: Identification of the International High-Risk Clone Sequence Type 235.
Hayashi W; Izumi K; Yoshida S; Takizawa S; Sakaguchi K; Iyori K; Minoshima KI; Takano S; Kitagawa M; Nagano Y; Nagano N
Microbiol Spectr; 2021 Oct; 9(2):e0040821. PubMed ID: 34585944
[TBL] [Abstract][Full Text] [Related]
4. Difference of Type 3 secretion system (T3SS) effector gene genotypes (exoU and exoS) and its implication to antibiotics resistances in isolates of Pseudomonas aeruginosa from chronic otitis media.
Park MH; Kim SY; Roh EY; Lee HS
Auris Nasus Larynx; 2017 Jun; 44(3):258-265. PubMed ID: 27461174
[TBL] [Abstract][Full Text] [Related]
5. Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening.
Hu H; Harmer C; Anuj S; Wainwright CE; Manos J; Cheney J; Harbour C; Zablotska I; Turnbull L; Whitchurch CB; Grimwood K; Rose B;
Clin Microbiol Infect; 2013 Mar; 19(3):266-72. PubMed ID: 22329595
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of biofilm production and characterization of genes encoding type III secretion system among Pseudomonas aeruginosa isolated from burn patients.
Jabalameli F; Mirsalehian A; Khoramian B; Aligholi M; Khoramrooz SS; Asadollahi P; Taherikalani M; Emaneini M
Burns; 2012 Dec; 38(8):1192-7. PubMed ID: 22995427
[TBL] [Abstract][Full Text] [Related]
7. Development of loop-mediated isothermal amplification assays for genotyping of Type III Secretion System in Pseudomonas aeruginosa.
Shi H; Chen Z; Kan J
Lett Appl Microbiol; 2015 Oct; 61(4):361-6. PubMed ID: 26219625
[TBL] [Abstract][Full Text] [Related]
8. High frequency of the exoU+/exoS+ genotype associated with multidrug-resistant "high-risk clones" of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals.
Horna G; Amaro C; Palacios A; Guerra H; Ruiz J
Sci Rep; 2019 Jul; 9(1):10874. PubMed ID: 31350412
[TBL] [Abstract][Full Text] [Related]
9. Molecular detection of different virulence factors genes harbor pslA, pelA, exoS, toxA and algD among biofilm-forming clinical isolates of Pseudomonas aeruginosa.
Farhan RE; Solyman SM; Hanora AM; Azab MM
Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):32-39. PubMed ID: 37571905
[TBL] [Abstract][Full Text] [Related]
10. Study on Virulence Genes of Type III Secretion System of Pseudomonas aeruginosa in Xinjiang Province.
Yi H; Sun Q; Wang X; Liu Y; Feng N; Zhang L; Song W; Shang X; Li X; Ma X
Clin Lab; 2021 Aug; 67(8):. PubMed ID: 34383413
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of multidrug-resistant (MDR) Pseudomonas aeruginosa isolated in a burn center.
de Almeida Silva KCF; Calomino MA; Deutsch G; de Castilho SR; de Paula GR; Esper LMR; Teixeira LA
Burns; 2017 Feb; 43(1):137-143. PubMed ID: 27595453
[TBL] [Abstract][Full Text] [Related]
12. The Impact of ExoS on
Kroken AR; Chen CK; Evans DJ; Yahr TL; Fleiszig SMJ
mBio; 2018 May; 9(3):. PubMed ID: 29717012
[No Abstract] [Full Text] [Related]
13. Presence of exoY, exoS, exoU and exoT genes, antibiotic resistance and biofilm production among Pseudomonas aeruginosa isolates in Northwest Iran.
Azimi S; Kafil HS; Baghi HB; Shokrian S; Najaf K; Asgharzadeh M; Yousefi M; Shahrivar F; Aghazadeh M
GMS Hyg Infect Control; 2016; 11():Doc04. PubMed ID: 26958458
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa.
Feltman H; Schulert G; Khan S; Jain M; Peterson L; Hauser AR
Microbiology (Reading); 2001 Oct; 147(Pt 10):2659-2669. PubMed ID: 11577145
[TBL] [Abstract][Full Text] [Related]
15. Higher Prevalence of PldA, a
Boulant T; Boudehen YM; Filloux A; Plesiat P; Naas T; Dortet L
Front Microbiol; 2018; 9():2578. PubMed ID: 30420847
[No Abstract] [Full Text] [Related]
16. Molecular detection of type III secretory toxins in Pseudomonas aeruginosa isolates.
Jarjees KK
Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):9-14. PubMed ID: 33040805
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of the virulence genes and their correlation with carbapenem resistance amongst the Pseudomonas aeruginosa strains isolated from a tertiary hospital in China.
Wang X; Gao K; Chen C; Zhang C; Zhou C; Song Y; Guo W
Antonie Van Leeuwenhoek; 2023 Dec; 116(12):1395-1406. PubMed ID: 37847452
[TBL] [Abstract][Full Text] [Related]
18. The Frequency of Exotoxin A and Exoenzymes S and U Genes Among Clinical Isolates of Pseudomonas aeruginosa in Shiraz, Iran.
Yousefi-Avarvand A; Khashei R; Sedigh Ebrahim-Saraie H; Emami A; Zomorodian K; Motamedifar M
Int J Mol Cell Med; 2015; 4(3):167-73. PubMed ID: 26629485
[TBL] [Abstract][Full Text] [Related]
19.
Sarges EDSNF; Rodrigues YC; Furlaneto IP; de Melo MVH; Brabo GLDC; Lopes KCM; Quaresma AJPG; Lima LNGC; Lima KVB
Infect Drug Resist; 2020; 13():3771-3781. PubMed ID: 33116695
[TBL] [Abstract][Full Text] [Related]
20. Association Between Biofilm Formation Gene Bla exoU and Metallo and Extend Spectrum Beta-lactamase Production of Multidrug Resistance Pseudomonas aeruginosa in Clinical Samples.
Ali FA
Comb Chem High Throughput Screen; 2022; 25(7):1207-1218. PubMed ID: 33874869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
